Table 3 Technical features and short-term safety outcomes
From: Non-target embolic events during prostatic embolization with ethylene vinyl alcohol copolymer (EVOH)
Variables | Data |
|---|---|
General anaesthesia, n (%) | 10 (100%) |
Bilateral femoral approach, n (%) | 10 (100%) |
Type of embolization, n (%) | |
Unilateral | 1(10%) |
Bilateral | 9 (90%) |
Total injected EVOH volume, mL | |
Mean ± SD | 0.8 (0.7–13) ± 0.4 |
Total PAE duration, min | |
Mean ± SD | 132 (120–150) ± 16 |
Fluoroscopic duration, min | |
Mean ± SD | 48 (32–55) ± 10 |
Radiation dose cgy.cm2 | |
Mean ± SD | 52927 (26389–72,152) ± 10230 |
Complications according to the Clavien–Dindo score, n (%) | |
IIIa | 2 (20%) |
NTEa, n | 1 |
General anaesthesia, n (%) | 10 (100%) |
Bilateral femoral approach, n (%) | 10 (100%) |
Type of embolization, n (%) | |
Unilateral | 1 (10%) |
Bilateral | 9 (90%) |
Total injected EVOH volume, Mean ± SD | 0.8 ± 0.4 mL |
Total PAE duration, Mean ± SD | 132 ± 16 min |
Fluoroscopic duration, Mean ± SD | 48 ± 10 min |
Radiation dose, Mean ± SD | 52,927 ± 10,230 cGy.cm2 |
Complications according to the Clavien‒Dindo score, n (%) | |
I | 0 (0%) |
II | 0 (0%) |
IIIa | 2 (20%) |
IIIb | 0 (0%) |
IVa | 0 (0%) |
IVb | 0 (0%) |
V | 0 (0%) |
NTE, n (%) | 1 (10%) |